The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 6, 2008, Pages 1220-1228

  Wang, Xiaohui ^a   Yang, Zhihong ^a   Zhang, Hao ^a   Ding, Lihua ^a   Li, Xiru ^b   Zhu, Cui ^a   Zheng, Yiqiong ^b   Ye, Qinong ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Estrogen receptor; Hematopoietic PBX interacting protein (HPIP); Interaction; Mitogen activated protein kinase (MAPK); Protein kinase B AKT

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEMATOPOIETIC PBX INTERACTING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 43549119039     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.01.026     Document Type: Article

References (43)

1. Ferguson A.T., and Davidson N.E. Regulation of estrogen receptor α function in breast cancer. Crit. Rev. Oncog. 8 (1997) 29-46
2. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 65 (2000) 227-251
3. Saji S., Jensen E.V., Nilsson S., Rylander T., Warner M., and Gustafsson J.A. Estrogen receptors α and β in the rodent mammary gland. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 337-342
4. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81 (2001) 1269-1304
5. McDonnell D.P., and Norris J.D. Connections and regulation of the human estrogen receptor. Science 296 (2002) 1642-1644
6. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354 (2006) 270-282
7. Gustafsson J.A. An update on estrogen receptors. Semin. Perinatol. 24 (2000) 66-69
8. Moggs J.G., and Orphanides G. Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep. 2 (2001) 775-781
9. Jordan V.C. Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 5 (2004) 207-213
10. Porter W., Saville B., Hoivik D., and Safe S. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11 (1997) 1569-1580
11. Teyssier C., Belguise K., Galtier F., and Chalbos D. Characterization of the physical interaction between estrogen receptor α and JUN proteins. J. Biol. Chem. 276 (2001) 36361-36369
12. Johnston S.R., Saccani-Jotti G., Smith I.E., Salter J., Newby J., Coppen M., Ebbs S.R., and Dowsett M. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res. 55 (1995) 3331-3338
13. Coradini D., Biganzoli E., Boracchi P., Bombardieri E., Seregni E., De-Palo G., Martelli G., and Di-Fronzo G. Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: an exploratory investigation. Int. J. Cancer 79 (1998) 305-311
14. Levin E.R. Cellular functions of plasma membrane estrogen receptors. Steroids 67 (2002) 471-475
15. Razandi M., Pedram A., Merchenthaler I., Greene G.L., and Levin E.R. Plasma membrane estrogen receptors exist and functions as dimmers. Mol. Endocrinol. 18 (2004) 2854-2865
16. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
17. Moriarty K., Kim K.H., and Bender J.R. Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147 (2006) 5557-5563
18. Osborne C.K., Schiff R., Fuqua S.A., and Shou J. Estrogen receptor: current understanding of its activation and modulation. Clin. Cancer Res. 7 (2001) 4338-4342
19. Lannigan D.A. Estrogen receptor phosphorylation. Steroids 68 (2003) 1-9
20. Song R.X., Zhang Z., and Santen R.J. Estrogen rapid action via protein complex formation involving ER and Src. Trends Endocrinol. Metab. 16 (2005) 347-353
21. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
22. Martin M.B., Franke T.F., Stoica G.E., Chambon P., Katzenellenbogen B.S., Stoica B.A., McLemore M.S., Olivo S.E., and Stoica A. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141 (2000) 503-511
23. Joel P.B., Traish A.M., and Lannigan D.A. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol. Endocrinol. 9 (1995) 1041-1052
24. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
25. Bunone G., Briand P.A., Miksicek R.J., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15 (1996) 2174-2183
26. Abramovich C., Shen W.F., Pineault N., Imren S., Montpetit B., Largman C., and Humphries R.K. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA. J. Biol. Chem. 275 (2000) 26172-26177
27. Abramovich C., Chavez E.A., Lansdorp P.M., and Humphries R.K. Functional characterization of multiple domains involved in the subcellular localization of the hematopoietic Pbx interacting protein (HPIP). Oncogene 21 (2002) 6766-6771
28. Ding L., Yan J., Zhu J., Zhong H., Lu Q., Wang Z., Huang C., and Ye Q. Ligand-independent activation of estrogen receptor α by XBP-1. Nucleic Acids Res. 31 (2003) 5266-5274
29. Zhang H., Xie X., Zhu X., Zhu J., Hao C., Lu Q., Ding L., Liu Y., Zhou L., Liu Y., Huang C., Wen C., and Ye Q. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. J. Biol. Chem. 280 (2005) 43188-43197
30. Han J., Ding L., Yuan B., Yang X., Wang X., Li J., Lu Q., Huang C., and Ye Q. Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells. Nucleic Acids Res. 34 (2006) 3095-3106
31. Manavathi B., Acconcia F., Rayala S.K., and Kumar R. An inherent role of microtubule network in the action of nuclear receptor. Proc. Natl Acad. Sci. U. S. A. 103 (2006) 15981-15986
32. Bardin A., Boulle N., Lazennec G., Vignon F., and Pujol P. Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer 11 (2004) 537-551
33. Matthews J., and Gustafsson J.A. Estrogen signaling: a subtle balance between ERα and ERβ. Mol. Interv. 3 (2003) 281-292
34. Speirs V., Carder P.J., Lane S., Dodwell D., Lansdown M.R., and Hanby A.M. Oestrogen receptor β: what it means for patients with breast cancer. Lancet. Oncol. 5 (2004) 174-181
35. Speirs V. Oestrogen receptor β in breast cancer: good, bad or still too early to tell?. J. Pathol. 197 (2002) 143-147
36. Hopp T.A., Weiss H.L., Parra I.S., Cui Y., Osborne C.K., and Fuqua S.A. Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer. Clin. Cancer Res. 10 (2004) 7490-7499
37. Saji S., Hirose M., and Toi M. Clinical significance of estrogen receptor β in breast cancer. Cancer Chemother. Pharmacol. 56 (2005) 21-26
38. Shaaban A.M., Jarvis C., Moore F., West C., Dodson A., and Foster C.S. Prognostic significance of estrogen receptor β in epithelial hyperplasia of usual type with known outcome. Am. J. Surg. Pathol. 29 (2005) 1593-1599
39. Fuqua S.A., Schiff R., Parra I., Friedrichs W.E., Su J.L., McKee D.D., Slentz-Kesler K., Moore L.B., Willson T.M., and Moore J.T. Expression of wild-type estrogen receptor β and variant isoforms in human breast cancer. Cancer Res. 59 (1999) 5425-5428
40. Fuqua S.A., Schiff R., Parra I., Moore J.T., Mohsin S.K., Osborne C.K., Clark G.M., and Allred D.C. Estrogen receptor β protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res. 63 (2003) 2434-2439
41. Sommer S., and Fuqua S.A. Estrogen receptor and breast cancer. Semin. Cancer Biol. 11 (2001) 339-352
42. Helguero L.A., Faulds M.H., Gustafsson J.A., and Haldosen L.A. Estrogen receptors (ERα) and (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24 (2005) 6605-6616
43. Omoto Y., Eguchi H., Yamamoto-Yamaguchi Y., and Hayashi S. Estrogen receptor (ER)β1 and ERβcx/2 inhibit ERα function differently in breast cancer cell line MCF7. Oncogene 22 (2003) 5011-5020